TLR2 and COVID-19: Interestingly, several of the enriched pathways, such as TLR2/4 signaling, Fc receptor signaling, and immune dysregulation during COVID-19, shared overlapping immune-suppressive or inflammatory traits, suggesting that ORMDL2 may be a broad coordinator of tumor inflammation, immune evasion, and apoptosis resistance.